BrandMemo | manage and share brands you love  Pharmamedix su Facebook  Pharmamedix su Twitter
 Home | News | About us | Comitato scientifico | Iscriviti | Utenti | Etica | Contenuti | Guida | Faq | Stage | Contatti
Logo Pharmamedix
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Zolmitriptan

Headzol, Zomig e altri

Bibliografia - Quali fonti bibliografiche per Zolmitriptan?


         
  1. Arulmani U. et al., Eur J Pharmacol, 2004, 500 (1–3), 315.

  2. Basu P. et al., Eur J Neurosci., 2015, 42 (7), 2489.

  3. Bird S. et al., Cochrane Database Syst. Rev., 2014, 5.

  4. Buzzi M.G., Moskowitz M.A., Pathol. Biol. (Paris), 1992, 40 (4), 313.

  5. Cameron C. et al., Headache, 2015, 55 (S4), 221.

  6. Charlesworth B.R. et al., CNS Drugs, 2003, 17 (9), 653.

  7. Chen L.C., Ashcroft D.M., Headache, 2008, 48 (2), 236.

  8. Dahlof C.G., Cephalalgia, 2006, 26 (2), 98.

  9. Di Piero V. et al., J. Headache Pain, 2004, 5 (S2), S78.

  10. Diener H.C., Katsarava Z., Curr. Med. Res. Opin., 2001, 17 (S1), S17.

  11. Dodick D.W. et al., Headache 2002, 42 (1), 1.

  12. Dodick D. et al., CNS Drugs, 2005, 19 (2), 125.

  13. Dodick D.W., Gargus J.J., Sci. Am., 2008, 299 (2), 56.

  14. Dowson A.J. et al., Cephalalgia, 2002, 22 (2), 101.

  15. Durham P.L., Headache, 2006, 46 (S1), S3.

  16. Earl N.L., Eur. Neurol, 1996, 36 (S2), 8.

  17. Edvinsson L., Headache, 2006, 46 (7), 1088.

  18. Evans R.W. et al., Headache, 2010, 50 (6), 1089.

  19. Farkkila M. et al., Cephalalgia, 2003, 23 (6), 463.

  20. Ferrari M.D., Eur. Neurol., 1996, 36 (S2), 19.

  21. Ferrari M.D., Neurology, 1997, 48 (3), S21.

  22. Gallagher R.M. et al., Headache, 2000, 40 (2), 119.

  23. Geraud G.E., Eur. Neurol., 1996, 36 (S2), 24.

  24. Géraud G. et al., Headache, 2003, 43 (4), 376.

  25. Goadsby P.J., Lance J.W., Rev. Prat., 1990, 40 (5), 389.

  26. Goldstein J. et al., Headache, 2006, 46 (7), 1142.

  27. Hamalainen et al., Duodecim., 2016, 132 (2), 187.

  28. Henderson L. et al., Br. J. Clin. Pharmacol., 2002, 54 (4), 349.

  29. Ismaiel A.M. et al., J. Med. Chem., 1997, 40 (26), 4415.

  30. Kilit C. et al., Neurol. India, 2015, 63 (6), 860.

  31. Lassen L.H. et al., Cephalalgia, 2002, 22 (1), 54.

  32. Lewis D.W. et al., Pediatrics, 2007, 120 (2), 390.

  33. Martin G.R., Eur. Neurol., 1996, 36 (S2), 13.

  34. Orlova Y et al., JAMA Neurol., 2018, doi: 10.1001/jamaneurol.2017.5144.

  35. Richer L. et al., Cochrane Database Syst. Rev., 2016, 4.

  36. Soldin O.P. et al., Ther. Drug Monit., 2008, 30 (1), 5.

  37. Stockley's Drug Interactions, 5-HT1 agonists (triptans) + selective serotonin re-uptake inhibitors, 6th edition 2002; 898.

  38. Tfelt-Hansen P. et al., Drugs, 2000, 60 (6), 1259.

  39. Thomsen L.L. et al., Cephalalgia, 1996, 16 (4), 270.

  40. Tokuoka K. et al., J Headache Pain, 2015, 16, 71.

  41. Vollono C. et al., Expert Rev Neurother., 2011, 11 (3), 395.

  42. Weinshank R.L. et al., Proc. Natl. Acad. Sci. U S A, 1992, 89 (8), 3630.

  43. Zagami A.S., Neurology, 1997, 48 (3), S25.